Banking Recap

M&A Transaction Announced for $2.50B

This is a cash acquisition structured as a take-private, classified under the M&A product group, in which Advent is acquiring Sapiens International Corporation N.V. The disclosed transaction value is $2,500,000,000. The facts block does not specify a sector classification for this record.

Aug 13, 2025·SEC EDGAR (6-K)·pending regulatory·cash acquisition / take-private

Deal value

The facts are sourced from a Form 6-K filed with the SEC via EDGAR, published on August 13, 2025. A 6-K is a filing type used by foreign private issuers, consistent with Sapiens' status as a Netherlands-incorporated company. The deal's current status is pending regulatory review.

Financial advisory roles are clearly delineated by side, with both advisors serving in a lead capacity. William Blair & Company, L.L.C. is acting as financial advisor to Sapiens, the target, per the statement "William Blair & Company, L.L.C. is acting as financial advisor to Sapiens, and Latham & Watkins LLP and Meitar Law Offices are acting as legal counsel to Sapiens." On the acquirer side, Citi is acting as financial advisor to Advent, consistent with the language "Citi is acting as financial advisor to Advent, and Kirkland & Ellis LLP and Herzog Fox Neeman are acting as legal counsel to Advent."

Legal advisors are disclosed for both sides, each with two firms reflecting the cross-border, Israel-linked nature of the deal. Latham & Watkins LLP and Meitar Law Offices are acting as legal counsel to Sapiens, the target. Kirkland & Ellis LLP and Herzog Fox Neeman are acting as legal counsel to Advent, the acquirer.

Beyond the classification of this transaction as a cash acquisition/take-private with a disclosed value of $2,500,000,000, no further detail on the per-share cash consideration or other specific terms is included in the facts provided.

Several items are not disclosed in this record: the per-share cash consideration is not specified, the sector classification is not given, and no expected closing date is given beyond the pending-regulatory status.